Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5278]

Neoadjuvant combination checkpoint blockade trial yields high response rates for patients with high-risk stage three melanoma

Neoadjuvant combination checkpoint blockade trial yields high response rates for patients with high-risk stage...

Nanopore technology with DNA computing easily detects microRNA patterns of lung cancer

Nanopore technology with DNA computing easily detects microRNA patterns of lung cancer

Novel technology enables detection of early-stage lung cancer when surgical cure still is possible

Novel technology enables detection of early-stage lung cancer when surgical cure still is possible

FDA approves cemiplimab-rwlc for metastatic or locally advanced cutaneous squamous cell carcinoma

FDA approves cemiplimab-rwlc for metastatic or locally advanced cutaneous squamous cell carcinoma

Analysis reveals genomic effects of a new cancer treatment now in clinical trials

Analysis reveals genomic effects of a new cancer treatment now in clinical trials

Analysis reveals genomic effects of a new cancer treatment now in clinical trials

Analysis reveals genomic effects of a new cancer treatment now in clinical trials

Duvelisib has marked response, survival benefit in difficult-to-treat leukaemia & lymphoma

Duvelisib has marked response, survival benefit in difficult-to-treat leukaemia & lymphoma

Colourful science - Success of melanoma immunotherapy stimulates clinical dermatology and pigment cell research

Colourful science - Success of melanoma immunotherapy stimulates clinical dermatology and pigment cell research

Age-related changes in skin structure & lymphatic system promote melanoma metastasis

Age-related changes in skin structure & lymphatic system promote melanoma metastasis

Could less deadly therapies be a better way to keep cancer in check?

Could less deadly therapies be a better way to keep cancer in check?

More from ecancer